PEPTIC
2020
Proton Pump Inhibitor versus Histamine-2 Receptor Blocker for Ulcer Prophylaxis
In 26,982 ventilated ICU patients, PPI prophylaxis did not change 90-day in-hospital mortality versus H₂-receptor antagonists.
Result
Efficacy: 90-day in-hospital mortalityRR 1.05
Below 1 favours PPI prophylaxis, above 1 favours H₂-receptor antagonists.
- Absolute difference
- 0.8 points
The absolute difference is derived from the event rates.
Also reported: No difference in infectious complications.
- Subtopic
- Stress-ulcer prophylaxis
- Design
- Cluster-randomised crossover trial, 50 ICUs across Australia, New Zealand, Canada, England, Ireland
- Relevance
- Supporting: context rather than must-know.
- Source
- PEPTIC Investigators. JAMA. 2020;323(7):616-626.doi 10.1001/jama.2019.22190
Discussion & critique
Either agent acceptable; modern preference is PPI based on REVISE.